3 Results for "

clinical cystic fibrosis isolates

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "clinical cystic fibrosis isolates" in MCE Product Catalog:

Cat. No.: HY-100045
CAS No.: 21064-69-7
Synonyms: 4-Nitrophenylphosphorylcholine; 4-Nitrophenylphosphorylcholine; O-(4-Nitrophenylphosphoryl)choline
p-Nitrophenyl phosphorylcholine (4-Nitrophenylphosphorylcholine) is a chromogenic Phospholipase C substrate. Phospholipase C hydrolyzes p-Nitrophenyl phosphorylcholine to release p-nitrophenol, a yellow chromophore. p-Nitrophenyl phosphorylcholine is used to determine the phospholipase C production of Pseudomonas aeruginosa. It also applies to studies related to Pseudomonas aeruginosa infection .
loading...
    loading...
Cat. No.: HY-182444
CAS No.: 859-07-4
Target:  

Antibiotic Bacterial

Research Areas:  

Infection

Cefaloram is a cephalosporin antibiotic, but it is inactive against clinical cystic fibrosis isolates of Pseudomonas aeruginosa (MIC50 > 128 μg/mL) .
loading...
    loading...
Cat. No.: HY-173277
CAS No.: 914357-88-3
Target:  

Bacterial

Research Areas:  

Infection

FtsZ-IN-13 (Compound C11) is an inhibitor of temperature-sensitive mutant Z (FtsZ), with IC50 values of 47.97, 34 μM against FtsZSa and FtsZPa, respectively. FtsZ-IN-13 has a notable antimicrobial activity against S. aureus (minimum inhibitory concentration value of 2 μg/mL), cystic fibrosis S. aureus clinical isolates, and methicillin-resistant S. aureus (MRSA) strains. FtsZ-IN-13 can be used for antimicrobial resistance study .
loading...
    loading...